US Broker Ratings

Universal Health Services, Inc. (UHS) Stock Analysis: Strong Growth Potential with 50% Upside

Universal Health Services, Inc. (NYSE: UHS), a key player in the healthcare sector with a focus on medical care facilities, currently stands out in the market with a robust potential..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Uncovering a Potential 51.92% Upside in the Biotechnology Sector

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is making waves in the biotechnology sector with its focus on developing innovative treatments for genetic diseases. With a market capitalization of $13.24 billion, this..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring Potential Upside with a 20.72% Gain

Teva Pharmaceutical Industries (NYSE: TEVA) is a formidable player in the global healthcare sector, renowned for its extensive portfolio of generic and specialty medicines. Based in Israel, this pharmaceutical giant..

Nuvalent, Inc. (NUVL) Stock Analysis: A Biotech Powerhouse with a 57.91% Potential Upside

Nuvalent, Inc. (NASDAQ: NUVL) is making waves in the biotechnology sector, capturing investor attention with a market cap of $7.18 billion and a compelling potential upside of 57.91%. Specializing in..

Lantheus Holdings, Inc. (LNTH): Analyst Consensus Highlights a Strong Buy with a 4.21% Upside Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH) has emerged as a noteworthy player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Based in Bedford, Massachusetts, Lantheus develops..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Unveiling a 23% Potential Upside for Investors

GE HealthCare Technologies Inc. (GEHC), a prominent player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for individual investors. With a market capitalization of $29.42 billion,..

Qiagen N.V. (QGEN) Stock Analysis: Exploring the 19.46% Potential Upside in Diagnostics Leadership

Qiagen N.V. (NYSE: QGEN), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, is attracting attention from investors thanks to its robust market position and..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Exploring Growth Potential and Analyst Ratings

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the medical devices industry, stands as a significant entity within the healthcare sector. With a market capitalization of $16.9 billion,..

Glaukos Corporation (GKOS) Stock Analysis: A Promising 23.6% Upside Potential in the Healthcare Sector

Glaukos Corporation (NYSE: GKOS) is making waves in the healthcare sector, capturing investor attention with its promising growth potential and innovative product offerings. As a key player in the medical..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: A 124% Upside Potential in the Biotech Sector

Telix Pharmaceuticals Limited (TLX), an Australian biotechnology firm, has captured the attention of investors with its promising pipeline and significant market potential. Operating in the healthcare sector, Telix is focused..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Strong Buy Ratings and 38.87% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) stands as a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in South Jordan, Utah, the company..

ICON plc (ICLR) Stock Analysis: Navigating the Healthcare Research Landscape with Promising Revenue Growth

ICON plc (NASDAQ: ICLR), an influential player in the healthcare sector, has carved a niche in the diagnostics and research industry. Based in Dublin, Ireland, ICON is a prominent clinical..

Cencora, Inc. (COR) Stock Analysis: Strong Buy Ratings and 29.74% Potential Upside Spark Investor Interest

Cencora, Inc. (NYSE: COR), a pivotal player in the healthcare sector, is emerging as a promising opportunity for investors seeking exposure to the medical distribution industry. With a formidable market..

Takeda Pharmaceutical Company L (TAK): Analyst Consensus and Potential 30.96% Upside for Investors

Takeda Pharmaceutical Company Limited (NYSE: TAK) presents a compelling opportunity for investors in the healthcare sector, particularly those interested in the specialty and generic drug manufacturing industry. As one of..

Ionis Pharmaceuticals (IONS) Stock Analysis: Exploring a 35.5% Upside Potential Amid Robust Revenue Growth

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a leading player in the biotechnology sector, is attracting significant investor interest with a compelling potential upside of 35.5%. With its innovative RNA-targeted therapies and..

Align Technology, Inc. (ALGN) Stock Analysis: Potential 24.64% Upside as Analysts Spotlight Growth Potential

Align Technology, Inc. (NASDAQ: ALGN), a prominent player in the medical instruments and supplies sector, is capturing investor attention with its innovative solutions in orthodontics and intraoral scanning systems. Headquartered..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a Potential 14.32% Upside for Investors

Smith & Nephew SNATS, Inc. (SNN), a prominent player in the healthcare sector, specifically within the medical devices industry, is garnering attention with its substantial market cap of $12.98 billion...

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Uncovering a 17.29% Potential Upside with Strong Revenue Growth

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a key player in the biotechnology sector, has captured the attention of investors with its innovative approach to drug delivery using proprietary enzyme technology. With..

Regencell Bioscience Holdings L (RGC) Stock Analysis: Navigating the Uncharted Path in TCM Bioscience

Regencell Bioscience Holdings Limited (NASDAQ: RGC) stands at the intersection of traditional Chinese medicine (TCM) and modern healthcare, carving a niche in the drug manufacturing industry with a focus on..

Elanco Animal Health (ELAN) Stock Analysis: A 26% Upside Potential in the Healthcare Sector

Elanco Animal Health Incorporated (NYSE: ELAN) is making waves in the healthcare sector, standing out as a prominent player in the animal health industry. With a market capitalization of $11.8..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds